The dreaded patent cliff is fast approaching for Merck’s flagship blockbuster, but the deck might be stacked against its ...

Anthropic is setting the stage for the largest IPO in history and Akeso has been touting its latest positive results for its ...

Novo failed to prove that Lilly’s campaign — which featured claims of obesity drug superiority — meaningfully harmed the ...

As the industry donates and lobbies in both political directions, ongoing drug policy issues and a new head of PhRMA could ...

The line between educating healthcare professionals and wooing them can still be fuzzy, which is impacting what doctors ...

However, despite this progress, the bioprocessing industry still struggles to use this data in a way that consistently ...

Despite an uptick in dealmaking and IPOs, a selective funding market and scientific setbacks are still pushing some biotechs ...

Parexel’s Stacy Hurt draws on her experience with chemotherapy and as a caregiver to spot patient burdens that AI-assisted ...